Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 4334 citations as per Google Scholar report
Sanjay Jaiswal
Posters-Accepted Abstracts: J Alzheimers Dis Parkinsonism
Dystonia, defined as a neurological syndrome characterised by involuntary, patterned, sustained, or repetitive muscle
contractions of opposing muscles, causing twisting movements and abnormal postures, is one of the most disabling
movement disorders. A small portion of patients have a known cause and respond to specific treatments, such as levodopa
in dopa-responsive dystonia or drugs that prevent copper accumulation in Wilson’s disease. Therapeutic options must be
tailored to the needs of individual patients. In patients on chronic dopaminergic treatment, peak-dose dystonia, diphasic
dystonia and off-dystonia can be seen. The later constitutes the major dystonic feature of chronic levodopa therapy, and a wide
variety of strategies are available to manage this complication. Many therapeutic options are available viz. Chemo-denervation
with botulinum toxin injections and medical treatments. Among them, Deep Brain Stimulation (DBS) of the sub-thalamic
nucleus has proved to be the most effective one. Parkinsonian tremor is most likely due to oscillating neuronal activity within
the CNS. The most likely candidate producing these oscillations is the basal ganglia loop and its topographic organization
might be responsible for the separation into different oscillators which, nevertheless, usually produce the same frequency. The
relative efficacy of trihexiphenidyl hydrochloride, amantadine hydrochloride, and low-dose carbidopa-levodopa in reducing
Parkinsonian tremors was investigated using objective techniques. Trihexiphenidyl and carbidopa-levodopa decreased tremor
by greater than 50%. Some patients responded to one drug but not to the other. Amantadine decreased tremor less than 25%.
Monotherapy with trihexiphenidyl or carbidopa-levodopa should be the initial treatment for the tremor of Parkinson’s disease.
Sanjay Jaiswal has completed his MD from RNT Medical College, Udaipur, India and DM Neurology from Institute of Medical Sciences BHU, Varanasi, India. He is
a Consultant Neurologist at Jaiswal Hospital and Neuro Institute, Kota, Rajasthan, India. He has published several papers in reputed journals and has been serving
as a Faculty in most of the neurology conferences. He has got an extensive experience of organizing and conducting conferences in the field of neurology and has
been awarded by State Government for the contribution to social welfare.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals